Download Files:
Products Details
Product Description
– Cofirasersen sodium is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Web ID
– HY-139786A
Shipping
– Room temperature
Molecular Formula
– C172H202N57Na16O88P15S15
References
– [1]WHO Drug Information, Vol. 34, No. 3, 2020
Molecular Weight
– 5789.18
SMILES
– [Cofirasersen (sodium)]
Clinical Information
– No Development Reported
Research Area
– Others
Solubility
– 10 mM in H2O
Target
– Sodium Channel
Pathway
– Membrane Transporter/Ion Channel
Product type
– Oligonucleotides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
